Update - bionano genomics hosts day 1 of 2022 symposium with six presentations highlighting the superior performance of ogm in variant detection for constitutional genetic diseases

San diego, jan. 10, 2022 (globe newswire) -- bionano genomics, inc. (bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™, the leading software solutions for visualization, interpretation and reporting of genomic data, hosted today the first of four days of 2022 symposium, the company's premiere event showcasing ogm research applications across key clinical areas of constitutional genetic disease, hematologic malignancies, solid tumors and ogm combined with next-generation sequencing (ngs).
BNGO Ratings Summary
BNGO Quant Ranking